Professional
Added to YB: 2025-04-14
Pitch date: 2025-03-31
MEDP [bullish]
Medpace Holdings, Inc.
+98.88%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$16.9B
Pitch Price
$305.85
Price Target
N/A
Dividend
N/A
EV/EBITDA
25.24
P/E
35.52
EV/Sales
5.95
Sector
Life Sciences Tools and Services
Category
growth
Vulcan Value Partners Large Cap Review New Position: Medpace Holdings, Inc.
MEDP (new position): Global CRO for small/mid biotech. Full-service model, less price-sensitive clients. Strong FCF & balance sheet. Double-digit earnings growth, flat 2025, then resume. Excellent management & capital allocation. Attractive long-term hold despite near-term slowdown.
Read full article (1 min)